PharmiWeb.com Press Releases https://www.pharmiweb.com PharmiWeb.com | Press Releases in the Pharmaceutical industry Fri, 13 Mar 2026 08:33:52 +00:00 en-GB hourly 1 TRNR Updates FAQ's & Investor Deck Following Ergatta Closing and Increased Guidance to more than $30 Million in 2026 Pro Forma Revenue https://www.pharmiweb.com/press-release/2026-03-13/trnr-updates-faqs-investor-deck-following-ergatta-closing-and-increased-guidance-to-more-than-30 Fri, 13 Mar 2026 12:40:00 +00:00 230136 KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility https://www.pharmiweb.com/press-release/2026-03-13/koru-medical-systems-announces-eu-mdr-certification-for-the-freedom60-infusion-pump-with-prefilled Fri, 13 Mar 2026 03:00:00 +00:00 230134 bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung https://www.pharmiweb.com/press-release/2026-03-13/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagn Fri, 13 Mar 2026 03:00:00 +00:00 230135 ImmunityBio Achieves Milestone with Large-Scale NK Cell Production and Cryopreservation from Over 60 Healthy and Cancer Donors https://www.pharmiweb.com/press-release/2026-03-13/immunitybio-achieves-milestone-with-large-scale-nk-cell-production-and-cryopreservation-from-over-60 Fri, 13 Mar 2026 02:30:00 +00:00 230128 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-13/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Fri, 13 Mar 2026 01:51:00 +00:00 230130 Black Book: Spain's Hospital IT Race Has Shifted from National Progress to Regional Performance https://www.pharmiweb.com/press-release/2026-03-13/black-book-spains-hospital-it-race-has-shifted-from-national-progress-to-regional-performance Fri, 13 Mar 2026 08:35:00 +00:00 230133 Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction https://www.pharmiweb.com/press-release/2026-03-13/wellgistics-president-releases-letter-to-shareholder-on-emerging-patient-care-centric-strategic-dire Fri, 13 Mar 2026 09:00:00 +00:00 230132 TIXiMED Announces Expansion of Program-Related Investment from the Helmsley Charitable Trust https://www.pharmiweb.com/press-release/2026-03-13/tiximed-announces-expansion-of-program-related-investment-from-the-helmsley-charitable-trust Fri, 13 Mar 2026 01:00:00 +00:00 230129 Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results https://www.pharmiweb.com/press-release/2026-03-13/xenetic-biosciences-inc-reports-full-year-2025-financial-results Fri, 13 Mar 2026 08:00:00 +00:00 230131 Innovations in Biomarker Detection Transform the Circulating Tumor Cells Market Landscape https://www.pharmiweb.com/press-release/2026-03-13/innovations-in-biomarker-detection-transform-the-circulating-tumor-cells-market-landscape Fri, 13 Mar 2026 04:47:49 +00:00 230109 NADMED Partners with Altheome to Bring Advanced NAD Testing to UK Clinics and Consumers https://www.pharmiweb.com/press-release/2026-03-12/nadmed-partners-with-altheome-to-bring-advanced-nad-testing-to-uk-clinics-and-consumers Thu, 12 Mar 2026 04:31:48 +00:00 230077 Brown Fat Starts at the Aorta https://www.pharmiweb.com/press-release/2026-03-12/brown-fat-starts-at-the-aorta Thu, 12 Mar 2026 11:25:51 +00:00 230035 Aplagon Announces First Patient Dosed in Phase 2a Clinical Trial of APAC in Patients with Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia https://www.pharmiweb.com/press-release/2026-03-13/aplagon-announces-first-patient-dosed-in-phase-2a-clinical-trial-of-apac-in-patients-with-peripheral-arterial-occlusive-disease-chronic-limb-threate Fri, 13 Mar 2026 09:50:14 +00:00 230127 Electric Wheelchair Market 2026 | Size, Share, Trends, and Growth by Forecast, 2035 https://www.pharmiweb.com/press-release/2026-03-13/electric-wheelchair-market-2026-size-share-trends-and-growth-by-forecast-2035 Fri, 13 Mar 2026 06:13:58 +00:00 230125 Fluticasone Propionate Market Size to Reach USD 6.97 Billion by 2032 Driven by Rising Respiratory Disorders https://www.pharmiweb.com/press-release/2026-03-13/fluticasone-propionate-market-size-to-reach-usd-697-billion-by-2032-driven-by-rising-respiratory-disorders Fri, 13 Mar 2026 06:09:04 +00:00 230123 3D Bioprinting Market Executive Summary, Segmentation, Review, Trends, Opportunities, Growth, Demand and Forecast to 2029 https://www.pharmiweb.com/press-release/2026-03-13/3d-bioprinting-market-executive-summary-segmentation-review-trends-opportunities-growth-demand-and-forecast-to-2029 Fri, 13 Mar 2026 05:50:39 +00:00 230121 Obesity Drugs Market Research Report, Analysis, Key Drivers, Top Players, Trends and Forecast 2031 https://www.pharmiweb.com/press-release/2026-03-13/obesity-drugs-market-research-report-analysis-key-drivers-top-players-trends-and-forecast-2031 Fri, 13 Mar 2026 05:48:05 +00:00 230119 MedTech Market 2026 | Size, Share, Growth, Report Analysis, Demand by Forecast to 2031 https://www.pharmiweb.com/press-release/2026-03-13/medtech-market-2026-size-share-growth-report-analysis-demand-by-forecast-to-2031 Fri, 13 Mar 2026 05:46:08 +00:00 230117 3D Printed Wearables Market Research Report, Analysis, Size, Share, Growth and Forecast 2026-2031 https://www.pharmiweb.com/press-release/2026-03-13/3d-printed-wearables-market-research-report-analysis-size-share-growth-and-forecast-2026-2031 Fri, 13 Mar 2026 05:36:25 +00:00 230116 Surgical Sutures Market Share Leaders, Market Analysis, Developments and Regional Forecast 2031 https://www.pharmiweb.com/press-release/2026-03-13/surgical-sutures-market-share-leaders-market-analysis-developments-and-regional-forecast-2031 Fri, 13 Mar 2026 05:35:05 +00:00 230114 Neonatal Intensive Care Respiratory Devices Market: Global Market Growth Study, Future Trends, Demands, and Top Players Data by Forecast to 2031 https://www.pharmiweb.com/press-release/2026-03-13/neonatal-intensive-care-respiratory-devices-market-global-market-growth-study-future-trends-demands-and-top-players-data-by-forecast-to-2031 Fri, 13 Mar 2026 05:32:52 +00:00 230113 Calcium Phosphate Bone Cement Market Size to Reach USD 1.30 Billion by 2032 Amid Rising Orthopedic Procedures https://www.pharmiweb.com/press-release/2026-03-13/calcium-phosphate-bone-cement-market-size-to-reach-usd-130-billion-by-2032-amid-rising-orthopedic-procedures Fri, 13 Mar 2026 04:51:54 +00:00 230111 Desert Oasis Healthcare Placed in the Top Tier of California Medical Groups with Coveted 4.5-Star Recognition https://www.pharmiweb.com/press-release/2026-03-13/desert-oasis-healthcare-placed-in-the-top-tier-of-california-medical-groups-with-coveted-45-star-re Fri, 13 Mar 2026 05:00:00 +00:00 230126 Soleno Therapeutics, Inc. (SLNO) Investors: May 5, 2026, Deadline in Securities Fraud Class Action Lawsuit – Contact Kessler Topaz Meltzer & Check, LLP https://www.pharmiweb.com/press-release/2026-03-13-2/soleno-therapeutics-inc-slno-investors-may-5-2026-deadline-in-securities-fraud-class-action-l Fri, 13 Mar 2026 02:33:00 +00:00 230097 Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments https://www.pharmiweb.com/press-release/2026-03-13-3/aptar-pharma-and-covirix-medical-partner-to-develop-inhalable-antiviral-treatments Fri, 13 Mar 2026 01:00:00 +00:00 230099 AV Laboratories Appoints Dr. Dendy Engelman to Scientific Advisory Board https://www.pharmiweb.com/press-release/2026-03-13-1/av-laboratories-appoints-dr-dendy-engelman-to-scientific-advisory-board Fri, 13 Mar 2026 12:10:00 +00:00 230090 Stevanato Group to Participate in the KeyBanc Capital Markets Virtual Healthcare Forum https://www.pharmiweb.com/press-release/2026-03-12/stevanato-group-to-participate-in-the-keybanc-capital-markets-virtual-healthcare-forum Thu, 12 Mar 2026 11:45:00 +00:00 230095 Colgate-Palmolive Announces Quarterly Dividend Increase and Elects Christopher Boerner, Ph.D. to Board of Directors https://www.pharmiweb.com/press-release/2026-03-12/colgate-palmolive-announces-quarterly-dividend-increase-and-elects-christopher-boerner-phd-to-boa Thu, 12 Mar 2026 11:30:00 +00:00 230091 KORU Medical Systems Announces +20% Fourth Quarter and Full Year 2025 Revenue Growth, Positive Adjusted EBITDA and Initiates Full Year 2026 Guidance https://www.pharmiweb.com/press-release/2026-03-12/koru-medical-systems-announces-plus20-fourth-quarter-and-full-year-2025-revenue-growth-positive-adjus Thu, 12 Mar 2026 11:05:00 +00:00 230092 Adicet Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress https://www.pharmiweb.com/press-release/2026-03-12/adicet-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-highlights-recent-company Thu, 12 Mar 2026 11:00:00 +00:00 230093 Beren Therapeutics Presents Data Supporting the Efficacy of Adrabetadex in Infantile-Onset NPC at 2026 ACMG Clinical Genetics Meeting https://www.pharmiweb.com/press-release/2026-03-12/beren-therapeutics-presents-data-supporting-the-efficacy-of-adrabetadex-in-infantile-onset-npc-at-20 Thu, 12 Mar 2026 11:00:00 +00:00 230094 eXoZymes' CCO Damien Perriman to Present a NCT Solution at Next Week's MISTA Symposium https://www.pharmiweb.com/press-release/2026-03-12/exozymes-cco-damien-perriman-to-present-a-nct-solution-at-next-weeks-mista-symposium Thu, 12 Mar 2026 04:15:00 +00:00 230088 Onco-Innovations Announces Closing of Private Placement https://www.pharmiweb.com/press-release/2026-03-12/onco-innovations-announces-closing-of-private-placement Thu, 12 Mar 2026 05:00:00 +00:00 230087 eClinical Solutions Appoints Lauren Whitsell as Chief Operating Officer and Venu Mallarapu as Chief Transformation and AI Officer https://www.pharmiweb.com/press-release/2026-03-12/eclinical-solutions-appoints-lauren-whitsell-as-chief-operating-officer-and-venu-mallarapu-as-chief Thu, 12 Mar 2026 09:09:00 +00:00 230082 Champions Oncology Reports Revenue of $16.6 Million https://www.pharmiweb.com/press-release/2026-03-12/champions-oncology-reports-revenue-of-166-million Thu, 12 Mar 2026 04:01:00 +00:00 230083 AM Best Affirms Credit Ratings of Torreyana Insurance Company, Inc. https://www.pharmiweb.com/press-release/2026-03-12/am-best-affirms-credit-ratings-of-torreyana-insurance-company-inc Thu, 12 Mar 2026 05:13:00 +00:00 230075 Increased Remote Patient Monitoring Services and how HumHealth Helps with Patient Success https://www.pharmiweb.com/press-release/2026-03-12/increased-remote-patient-monitoring-services-and-how-humhealth-helps-with-patient-success Thu, 12 Mar 2026 12:40:00 +00:00 230078 Five PGIM Funds Recognized by 2026 LSEG Lipper Fund Awards https://www.pharmiweb.com/press-release/2026-03-12/five-pgim-funds-recognized-by-2026-lseg-lipper-fund-awards Thu, 12 Mar 2026 04:30:00 +00:00 230050 Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing https://www.pharmiweb.com/press-release/2026-03-12/owkin-creates-new-spin-out-waiv-formerly-owkin-dx-with-33m-financing Thu, 12 Mar 2026 04:30:00 +00:00 230051 FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer https://www.pharmiweb.com/press-release/2026-03-12/fujifilm-biotechnologies-appoints-christiane-bardroff-as-chief-business-officer Thu, 12 Mar 2026 04:30:00 +00:00 230052 RQM+ Launches SMART Solutions Life Cycle Partnership Model https://www.pharmiweb.com/press-release/2026-03-12/rqmplus-launches-smart-solutions-life-cycle-partnership-model Thu, 12 Mar 2026 04:30:00 +00:00 230065 Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting https://www.pharmiweb.com/press-release/2026-03-12/otsuka-unveils-new-repinatrabit-open-label-extension-data-in-phenylketonuria-pku-signaling-efficac Thu, 12 Mar 2026 04:10:00 +00:00 230053 Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences https://www.pharmiweb.com/press-release/2026-03-12/enodia-therapeutics-strengthens-sec61-portfolio-through-acquisition-of-preclinical-assets-from-kezar Thu, 12 Mar 2026 04:00:00 +00:00 230054 Waiv Secures $33 Million to Scale AI Precision Testing https://www.pharmiweb.com/press-release/2026-03-12/waiv-secures-33-million-to-scale-ai-precision-testing Thu, 12 Mar 2026 04:00:00 +00:00 230055 PsiQuantum and National Cancer Center Japan Announce New Strategic Partnership to Accelerate Drug Discovery for Healthcare https://www.pharmiweb.com/press-release/2026-03-12/psiquantum-and-national-cancer-center-japan-announce-new-strategic-partnership-to-accelerate-drug-di Thu, 12 Mar 2026 04:00:00 +00:00 230056 Xiid Becomes Security Backbone for EV, Healthcare AI, and Specialized Cloud and DevOps Consultancy https://www.pharmiweb.com/press-release/2026-03-12/xiid-becomes-security-backbone-for-ev-healthcare-ai-and-specialized-cloud-and-devops-consultancy Thu, 12 Mar 2026 04:00:00 +00:00 230057 Dosell AB Signs Framework Agreement with Adda Following the End of the Appeal Period https://www.pharmiweb.com/press-release/2026-03-12/dosell-ab-signs-framework-agreement-with-adda-following-the-end-of-the-appeal-period-1 Thu, 12 Mar 2026 11:15:00 +00:00 230074 Action Behavior Centers Hosts Community Impact Event with The Kindness Campaign(R) During Annual Leadership Summit https://www.pharmiweb.com/press-release/2026-03-12/action-behavior-centers-hosts-community-impact-event-with-the-kindness-campaign-r-during-annual-lea Thu, 12 Mar 2026 11:45:00 +00:00 230073 Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study https://www.pharmiweb.com/press-release/2026-03-12/intensity-therapeutics-inc-provides-update-on-the-phase-2-presurgical-triple-negative-breast-cancer-invincible-4-study Thu, 12 Mar 2026 03:33:31 +00:00 230072 Dosell AB signs framework agreement with Adda following the end of the appeal period https://www.pharmiweb.com/press-release/2026-03-12/dosell-ab-signs-framework-agreement-with-adda-following-the-end-of-the-appeal-period Thu, 12 Mar 2026 03:32:33 +00:00 230071 Shilpa Biologicals and mAbTree Biologics Secure Orphan Drug Designation from U.S. FDA https://www.pharmiweb.com/press-release/2026-03-12/shilpa-biologicals-and-mabtree-biologics-secure-orphan-drug-designation-from-us-fda Thu, 12 Mar 2026 03:31:27 +00:00 230070 Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management https://www.pharmiweb.com/press-release/2026-03-12/landmark-study-shows-libre-technology-helps-people-with-type-2-diabetes-on-basal-insulin-improve-glucose-management Thu, 12 Mar 2026 03:30:39 +00:00 230069 ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026 https://www.pharmiweb.com/press-release/2026-03-12/elrig-announces-prof-hazel-screen-and-dr-dave-powell-as-keynote-speakers-for-advances-in-cell-based-screening-2026 Thu, 12 Mar 2026 11:37:57 +00:00 230037 Asylon Robotics Announces New Advisors, Additions to Leadership Team https://www.pharmiweb.com/press-release/2026-03-12/asylon-robotics-announces-new-advisors-additions-to-leadership-team Thu, 12 Mar 2026 03:20:00 +00:00 230058 Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel https://www.pharmiweb.com/press-release/2026-03-12/atara-biotherapeutics-provides-regulatory-update-on-tabelecleucel Thu, 12 Mar 2026 03:05:00 +00:00 230059 Carna Health Marks World Kidney Day with Scaling of CKD Screening Program to Four Continents https://www.pharmiweb.com/press-release/2026-03-12/carna-health-marks-world-kidney-day-with-scaling-of-ckd-screening-program-to-four-continents Thu, 12 Mar 2026 03:00:00 +00:00 230060 Inocras and NDS Partner to Deliver Clinical-Scale Whole-Genome Cancer Analytics in the Cloud https://www.pharmiweb.com/press-release/2026-03-12/inocras-and-nds-partner-to-deliver-clinical-scale-whole-genome-cancer-analytics-in-the-cloud Thu, 12 Mar 2026 03:00:00 +00:00 230061 Korsana Biosciences to Present at the Stifel 2026 Virtual CNS Forum https://www.pharmiweb.com/press-release/2026-03-12/korsana-biosciences-to-present-at-the-stifel-2026-virtual-cns-forum Thu, 12 Mar 2026 03:00:00 +00:00 230062 David Ke Joins Evercore as Senior Managing Director in the Equity Capital Markets Group https://www.pharmiweb.com/press-release/2026-03-12/david-ke-joins-evercore-as-senior-managing-director-in-the-equity-capital-markets-group Thu, 12 Mar 2026 03:00:00 +00:00 230063 Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients https://www.pharmiweb.com/press-release/2026-03-12/johnson-johnson-announces-fda-approval-of-tecnis-puresee-intraocular-lens-a-breakthrough-solution Thu, 12 Mar 2026 03:00:00 +00:00 230064 Communiqué from the Extraordinary General Meeting of iZafe Group AB https://www.pharmiweb.com/press-release/2026-03-12/communiqué-from-the-extraordinary-general-meeting-of-izafe-group-ab Thu, 12 Mar 2026 10:10:00 +00:00 230068 The Longevity Centers of America Expands Mental Wellness Services with Procaine IV Therapy for Stress and Anxiety Relief https://www.pharmiweb.com/press-release/2026-03-12/the-longevity-centers-of-america-expands-mental-wellness-services-with-procaine-iv-therapy-for-stres Thu, 12 Mar 2026 10:00:00 +00:00 230067 Faron Pharmaceuticals Ltd: Holding(s) in Company https://www.pharmiweb.com/press-release/2026-03-12/faron-pharmaceuticals-ltd-holding-s-in-company Thu, 12 Mar 2026 10:45:00 +00:00 230066 Baseimmune Announces Strategic Expansion into Fibrosis with Lead Program Targeting Idiopathic Pulmonary Fibrosis (IPF) https://www.pharmiweb.com/press-release/2026-03-12/baseimmune-announces-strategic-expansion-into-fibrosis-with-lead-program-targeting-idiopathic-pulmon Thu, 12 Mar 2026 02:00:00 +00:00 230040 Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update https://www.pharmiweb.com/press-release/2026-03-12/precision-biosciences-reports-fourth-quarter-and-fiscal-year-2025-financial-results-and-provides-bus Thu, 12 Mar 2026 02:00:00 +00:00 230043 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-12/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Thu, 12 Mar 2026 01:44:00 +00:00 230041 Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 https://www.pharmiweb.com/press-release/2026-03-12/compass-pathways-to-present-at-stifel-2026-virtual-cns-forum-on-march-18-2026 Thu, 12 Mar 2026 01:30:00 +00:00 230042 Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis https://www.pharmiweb.com/press-release/2026-03-12/everest-medicines-announces-commercial-launch-and-first-prescription-for-velsipity-r-in-mainland-china-addressing-unmet-need-in-moderately-to-severe Thu, 12 Mar 2026 03:06:28 +00:00 230033 Coulter Partners places Dr. David Rosenbaum as Chief Development Officer of Syntis Bio https://www.pharmiweb.com/press-release/2026-03-11/coulter-partners-places-dr-david-rosenbaum-as-chief-development-officer-of-syntis-bio Wed, 11 Mar 2026 03:19:42 +00:00 230010 Orbia Fluor & Energy Materials Accelerates U.S. Regulatory Pathway for its Low-GWP Propellant with Type IV DMF Registration https://www.pharmiweb.com/press-release/2026-03-11/orbia-fluor-energy-materials-accelerates-us-regulatory-pathway-for-its-low-gwp-propellant-with-type-iv-dmf-registration Wed, 11 Mar 2026 02:52:05 +00:00 230008 The Naderi Center Introduces Advanced PRF Injections Using the EZPRF Platform https://www.pharmiweb.com/press-release/2026-03-12/the-naderi-center-introduces-advanced-prf-injections-using-the-ezprf-platform Thu, 12 Mar 2026 08:00:00 +00:00 230049 Medical Care Technologies Inc. (OTC Pink:MDCE) Snapshot Recipes Ignites First Successful Monetization of AI Technology in the Smart Device Market https://www.pharmiweb.com/press-release/2026-03-12/medical-care-technologies-inc-otc-pinkmdce-snapshot-recipes-ignites-first-successful-monetizatio Thu, 12 Mar 2026 08:00:00 +00:00 230048 Black Book Unveils 2026 South Africa Acute Care EHR Report as NHI, POPIA, and Infrastructure Gaps Redefine Hospital IT Priorities https://www.pharmiweb.com/press-release/2026-03-12/black-book-unveils-2026-south-africa-acute-care-ehr-report-as-nhi-popia-and-infrastructure-gaps-re Thu, 12 Mar 2026 08:00:00 +00:00 230047 Justera Announces Director and Interim CEO Appointments https://www.pharmiweb.com/press-release/2026-03-12/justera-announces-director-and-interim-ceo-appointments Thu, 12 Mar 2026 08:00:00 +00:00 230046 Aspire Biopharma's Subsidiary to Feature BUZZ BOMB(TM) at The Health & Fitness Show 2026 https://www.pharmiweb.com/press-release/2026-03-12/aspire-biopharmas-subsidiary-to-feature-buzz-bomb-tm-at-the-health-fitness-show-2026 Thu, 12 Mar 2026 08:00:00 +00:00 230045 Tenon Medical Announces Closing of Private Placement of Senior Convertible Notes Offering for Gross Proceeds of $ 4.3 Million https://www.pharmiweb.com/press-release/2026-03-12/tenon-medical-announces-closing-of-private-placement-of-senior-convertible-notes-offering-for-gross Thu, 12 Mar 2026 08:30:00 +00:00 230044 New Relic to Launch Japanese Data Center to Accelerate Enterprise Digital Transformation and Operational Excellence https://www.pharmiweb.com/press-release/2026-03-12/new-relic-to-launch-japanese-data-center-to-accelerate-enterprise-digital-transformation-and-operati Thu, 12 Mar 2026 06:00:00 +00:00 230034 C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests to Help Doctors Diagnose Alzheimer’s Disease https://www.pharmiweb.com/press-release/2026-03-11/c2n-diagnostics-enters-south-korean-market-through-partnership-with-beaubrain-healthcare-to-offer-pr Wed, 11 Mar 2026 11:30:00 +00:00 230027 Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance https://www.pharmiweb.com/press-release/2026-03-11/guardian-pharmacy-services-reports-fourth-quarter-and-full-year-2025-financial-results-raises-2026 Wed, 11 Mar 2026 11:05:00 +00:00 230028 Evofem Reports Fifth Consecutive Year of Net Sales Growth https://www.pharmiweb.com/press-release/2026-03-11/evofem-reports-fifth-consecutive-year-of-net-sales-growth Wed, 11 Mar 2026 11:05:00 +00:00 230029 Avel eCare and Seven Corners Healthcare Announce Strategic Partnership to Expand Access and Continuity of Care https://www.pharmiweb.com/press-release/2026-03-11/avel-ecare-and-seven-corners-healthcare-announce-strategic-partnership-to-expand-access-and-continui Wed, 11 Mar 2026 04:10:00 +00:00 230025 nVenia Announces IPS Packaging & Automation as Official Distribution Partner in the Southeastern United States https://www.pharmiweb.com/press-release/2026-03-11/nvenia-announces-ips-packaging-automation-as-official-distribution-partner-in-the-southeastern-uni Wed, 11 Mar 2026 08:00:00 +00:00 230021 HIMSS Survey: 60% of Health Systems Can't Protect Unmanaged Medical Devices https://www.pharmiweb.com/press-release/2026-03-11/himss-survey-60-of-health-systems-cant-protect-unmanaged-medical-devices Wed, 11 Mar 2026 08:00:00 +00:00 230024 Hilgers Partners Recognized Among the Legal Industry’s AI Pacesetters https://www.pharmiweb.com/press-release/2026-03-11/hilgers-partners-recognized-among-the-legal-industry-s-ai-pacesetters Wed, 11 Mar 2026 07:29:00 +00:00 230022 EdgeOne Medical Welcomes Combination Product Pioneer Lee Leichter as Senior Advisor https://www.pharmiweb.com/press-release/2026-03-11/edgeone-medical-welcomes-combination-product-pioneer-lee-leichter-as-senior-advisor Wed, 11 Mar 2026 07:00:00 +00:00 230023 Gore Expands Leadership in Membrane Chromatography with Next-Generation Affinity Solutions https://www.pharmiweb.com/press-release/2026-03-11/gore-expands-leadership-in-membrane-chromatography-with-next-generation-affinity-solutions Wed, 11 Mar 2026 05:58:00 +00:00 230016 HealthTrust Advances the Future of Clinically Aligned Performance at 2026 FAH Conference https://www.pharmiweb.com/press-release/2026-03-11/healthtrust-advances-the-future-of-clinically-aligned-performance-at-2026-fah-conference Wed, 11 Mar 2026 05:38:00 +00:00 230019 AI Maverick Intel Announces Strategic Right of First Refusal Agreement with HEAL Group https://www.pharmiweb.com/press-release/2026-03-11/ai-maverick-intel-announces-strategic-right-of-first-refusal-agreement-with-heal-group Wed, 11 Mar 2026 01:00:00 +00:00 230020 Kion Gains Momentum with AI-Driven FinOps+ Platform https://www.pharmiweb.com/press-release/2026-03-11/kion-gains-momentum-with-ai-driven-finopsplus-platform Wed, 11 Mar 2026 05:00:00 +00:00 230017 iXCells Biotechnologies Reaches iPSC Line Delivery Milestone in Collaboration With Global Biotechnology Company https://www.pharmiweb.com/press-release/2026-03-11/ixcells-biotechnologies-reaches-ipsc-line-delivery-milestone-in-collaboration-with-global-biotechnol Wed, 11 Mar 2026 05:00:00 +00:00 230018 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-11/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Wed, 11 Mar 2026 04:38:00 +00:00 229999 Andersen Consulting Strengthens Platform with Collaborating Firm Ambit Iberia https://www.pharmiweb.com/press-release/2026-03-11/andersen-consulting-strengthens-platform-with-collaborating-firm-ambit-iberia Wed, 11 Mar 2026 04:30:00 +00:00 230006 Health Medicinals Expands Apotheco Medicinals as National Operations Platform https://www.pharmiweb.com/press-release/2026-03-11/health-medicinals-expands-apotheco-medicinals-as-national-operations-platform Wed, 11 Mar 2026 04:05:00 +00:00 230000 Healthier Comforts Brings EVERY’s Animal-Free Egg White Protein to Home Kitchens for the First Time https://www.pharmiweb.com/press-release/2026-03-11/healthier-comforts-brings-every-s-animal-free-egg-white-protein-to-home-kitchens-for-the-first-time Wed, 11 Mar 2026 04:00:00 +00:00 230001 GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications https://www.pharmiweb.com/press-release/2026-03-11/goodrx-partners-with-viatris-to-offer-up-to-85-savings-on-established-brand-medications Wed, 11 Mar 2026 04:00:00 +00:00 230002 SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America https://www.pharmiweb.com/press-release/2026-03-11/steincares-and-shilpa-biologicals-strike-into-licensing-agreement-to-expand-access-to-biosimilars-across-latin-america Wed, 11 Mar 2026 03:30:23 +00:00 230015 HarbourVest Releases Q3 2025 Private Equity Benchmark Performance Data https://www.pharmiweb.com/press-release/2026-03-11/harbourvest-releases-q3-2025-private-equity-benchmark-performance-data Wed, 11 Mar 2026 03:30:00 +00:00 230003 CellaVision launches Bone Marrow Aspirate Application in EMEA https://www.pharmiweb.com/press-release/2026-03-11/cellavision-launches-bone-marrow-aspirate-application-in-emea Wed, 11 Mar 2026 03:29:25 +00:00 230014 First patient dosed in Gesynta Pharma's endometriosis trial of vipoglanstat https://www.pharmiweb.com/press-release/2026-03-11/first-patient-dosed-in-gesynta-pharmas-endometriosis-trial-of-vipoglanstat Wed, 11 Mar 2026 03:28:28 +00:00 230013 Cognito Therapeutics Appoints Thomas Fagan as Executive Vice President, Alzheimer’s Portfolio https://www.pharmiweb.com/press-release/2026-03-11/cognito-therapeutics-appoints-thomas-fagan-as-executive-vice-president-alzheimer-s-portfolio Wed, 11 Mar 2026 03:00:00 +00:00 230004 Catalent and GelMEDIX Enter Global Partnership for the Development and Clinical Manufacturing of iPSC-Derived Cell Therapies in Ocular and Retinal Diseases https://www.pharmiweb.com/press-release/2026-03-11/catalent-and-gelmedix-enter-global-partnership-for-the-development-and-clinical-manufacturing-of-ips Wed, 11 Mar 2026 03:00:00 +00:00 230005 Neurogene to Participate in Stifel 2026 Virtual CNS Forum https://www.pharmiweb.com/press-release/2026-03-11/neurogene-to-participate-in-stifel-2026-virtual-cns-forum Wed, 11 Mar 2026 02:30:00 +00:00 229985 Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets https://www.pharmiweb.com/press-release/2026-03-11/veristat-expands-regulatory-and-clinical-services-to-chinese-drug-and-device-companies-seeking-effic Wed, 11 Mar 2026 02:05:00 +00:00 229989 NASA Awards Redwire $4 Million In Additional Funding to Support Trailblazing Drug Development in Microgravity https://www.pharmiweb.com/press-release/2026-03-11/nasa-awards-redwire-4-million-in-additional-funding-to-support-trailblazing-drug-development-in-mic Wed, 11 Mar 2026 02:00:00 +00:00 229986 Dr. Sean Doherty Recognized as Boston Magazine Top Doctors(TM) 2026 - Plastic Surgery https://www.pharmiweb.com/press-release/2026-03-11/dr-sean-doherty-recognized-as-boston-magazine-top-doctors-tm-2026-plastic-surgery Wed, 11 Mar 2026 09:00:00 +00:00 229998 Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts https://www.pharmiweb.com/press-release/2026-03-11/jaguar-health-presenting-march-12-at-the-life-sciences-virtual-investor-forum-to-provide-updates-on Wed, 11 Mar 2026 09:00:00 +00:00 229997 TRNR Completes Acquisition of Ergatta, Confirms Increased 2026 Pro Forma Revenue Guidance of $30m+ https://www.pharmiweb.com/press-release/2026-03-11/trnr-completes-acquisition-of-ergatta-confirms-increased-2026-pro-forma-revenue-guidance-of-30mplus Wed, 11 Mar 2026 09:05:00 +00:00 229996 Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site https://www.pharmiweb.com/press-release/2026-03-11/chiesi-and-bespak-partner-to-advance-carbon-minimal-inhaler-production-with-uk-manufacturing-site-1 Wed, 11 Mar 2026 01:00:00 +00:00 229987 Aplantex and Investissement Québec Team up to Produce Molecules for the Cosmetic and Food Industries https://www.pharmiweb.com/press-release/2026-03-11/aplantex-and-investissement-québec-team-up-to-produce-molecules-for-the-cosmetic-and-food-industries Wed, 11 Mar 2026 01:00:00 +00:00 229988 NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete https://www.pharmiweb.com/press-release/2026-03-11/nanoviricides-presenting-at-nibas-152nd-investment-conference-in-fort-lauderdale-fl-march-12-2026 Wed, 11 Mar 2026 08:30:00 +00:00 229993 Wellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification Capabilities https://www.pharmiweb.com/press-release/2026-03-11/wellgistics-strengthens-pharmacychain-tm-with-insurance-eligibility-benefits-verification-capabil Wed, 11 Mar 2026 08:30:00 +00:00 229992 CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline https://www.pharmiweb.com/press-release/2026-03-11/cns-pharmaceuticals-launches-new-corporate-strategy-focused-on-building-a-high-value-neurology-and-o Wed, 11 Mar 2026 08:35:00 +00:00 229991 Brainomix Deploys AI Imaging Platform Across West Virginia University (WVU) Health System Network to Support Stroke Care https://www.pharmiweb.com/press-release/2026-03-11/brainomix-deploys-ai-imaging-platform-across-west-virginia-university-wvu-health-system-network-to-support-stroke-care Wed, 11 Mar 2026 11:33:52 +00:00 229983 Chiesi and Bespak partner to advance Carbon Minimal Inhaler production with UK manufacturing site https://www.pharmiweb.com/press-release/2026-03-11/chiesi-and-bespak-partner-to-advance-carbon-minimal-inhaler-production-with-uk-manufacturing-site Wed, 11 Mar 2026 10:07:37 +00:00 229977 EnteroBiotix Announces Completion of Enrolment in Phase 2a Trial Evaluating EBX-102-02 Prior to Allogeneic Stem Cell Transplantation https://www.pharmiweb.com/press-release/2026-03-10/enterobiotix-announces-completion-of-enrolment-in-phase-2a-trial-evaluating-ebx-102-02-prior-to-allogeneic-stem-cell-transplantation-1 Tue, 10 Mar 2026 09:37:46 +00:00 229882 Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases https://www.pharmiweb.com/press-release/2026-03-11/revive-therapeutics-strengthens-bucillamine-ip-portfolio-with-north-american-patent-filings-for-nerv Wed, 11 Mar 2026 07:30:00 +00:00 229984 Cambridge Cognition Investment, Monument Therapeutics, Announces First Patient Dosed in Clinical Trial of MT1988 in Patients at Clinical High Risk for Psychosis https://www.pharmiweb.com/press-release/2026-03-11/cambridge-cognition-investment-monument-therapeutics-announces-first-patient-dosed-in-clinical-trial-of-mt1988-in-patients-at-clinical-high-risk-for Wed, 11 Mar 2026 10:52:18 +00:00 229980 National Health Service to offer VEOZA▼™ (fezolinetant) for the treatment of moderate-to-severe hot flushes and night-sweats associated with menopause when hormone replacement therapy is unsuitable. https://www.pharmiweb.com/press-release/2026-03-11/national-health-service-to-offer-veoza-fezolinetant-for-the-treatment-of-moderate-to-severe-hot-flushes-and-night-sweats-associated-with-menopause Wed, 11 Mar 2026 10:51:30 +00:00 229979 Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic https://www.pharmiweb.com/press-release/2026-03-11/commit-biologics-appoints-serial-biotech-founder-as-new-ceo-to-take-complement-powered-immune-engagers-into-the-clinic Wed, 11 Mar 2026 10:45:07 +00:00 229978 Codethink Opens Early Access to IEC 61508 Mapping for the Eclipse Trustable Software Framework https://www.pharmiweb.com/press-release/2026-03-11/codethink-opens-early-access-to-iec-61508-mapping-for-the-eclipse-trustable-software-framework Wed, 11 Mar 2026 10:07:00 +00:00 229971 EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx Therapy for Donor-Specific Immune Tolerance in Kidney Transplantation https://www.pharmiweb.com/press-release/2026-03-11/ema-grants-prime-designation-to-tolerogenixx-s-mic-lx-therapy-for-donor-specific-immune-tolerance-in-kidney-transplantation Wed, 11 Mar 2026 08:40:17 +00:00 229975 Allergy Diagnostics Market: Growth, Opportunities, Key Players & Forecast Outlook 2030 https://www.pharmiweb.com/press-release/2026-03-11/allergy-diagnostics-market-growth-opportunities-key-players-forecast-outlook-2030 Wed, 11 Mar 2026 05:49:27 +00:00 229961 Absorbable Sutures Market Growth Opportunity, Developments and Regional Forecast to 2026-2031 https://www.pharmiweb.com/press-release/2026-03-11/absorbable-sutures-market-growth-opportunity-developments-and-regional-forecast-to-2026-2031 Wed, 11 Mar 2026 05:43:04 +00:00 229959 Orthopedic Implants Market Size, Competitor Ranking Analysis, Market Trend Forecast Report 2025-2030 https://www.pharmiweb.com/press-release/2026-03-11/orthopedic-implants-market-size-competitor-ranking-analysis-market-trend-forecast-report-2025-2030 Wed, 11 Mar 2026 05:17:39 +00:00 229955 Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan https://www.pharmiweb.com/press-release/2026-03-11/curatis-and-neupharma-announce-exclusive-licensing-agreement-to-develop-and-market-corticorelin-c-p Wed, 11 Mar 2026 09:00:00 +00:00 229972 FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year https://www.pharmiweb.com/press-release/2026-03-11/ferm-food-acquires-orkla-s-former-site-and-scales-up-up-to-20-000-tonnes-of-fermented-ingredients-p Wed, 11 Mar 2026 09:00:00 +00:00 229973 Rosen Law Firm Urges Aquestive Therapeutics, Inc. (NASDAQ: AQST) Stockholders to Contact the Firm for Information About Their Rights https://www.pharmiweb.com/press-release/2026-03-11-2/rosen-law-firm-urges-aquestive-therapeutics-inc-nasdaq-aqst-stockholders-to-contact-the-firm-fo Wed, 11 Mar 2026 02:26:00 +00:00 229950 QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System https://www.pharmiweb.com/press-release/2026-03-11-1/qiagen-receives-us-clearance-for-gastrointestinal-panels-on-fully-automated-qiastat-dx-rise-syndro Wed, 11 Mar 2026 12:05:00 +00:00 229946 IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Application Lab https://www.pharmiweb.com/press-release/2026-03-10/iff-expands-latin-american-footprint-with-new-enzyme-hub-brazil-application-lab Tue, 10 Mar 2026 11:30:00 +00:00 229948 RGNX's Inadequate Risk Disclosures Allegedly Cost Investors $2.40/Share: Levi & Korsinsky, LLP https://www.pharmiweb.com/press-release/2026-03-10/rgnxs-inadequate-risk-disclosures-allegedly-cost-investors-240share-levi-korsinsky-llp Tue, 10 Mar 2026 11:00:00 +00:00 229947 CV Sciences Announces Successful Debt Restructuring Designed to Strengthen Financial Position and Fuel Future Growth https://www.pharmiweb.com/press-release/2026-03-10/cv-sciences-announces-successful-debt-restructuring-designed-to-strengthen-financial-position-and-fu Tue, 10 Mar 2026 05:00:00 +00:00 229944 The $30 Billion CBD Question: Should Medicare Reimburse Cannabis Products Without FDA Approval? https://www.pharmiweb.com/press-release/2026-03-10/the-30-billion-cbd-question-should-medicare-reimburse-cannabis-products-without-fda-approval Tue, 10 Mar 2026 04:00:00 +00:00 229943 TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessation in Obesity Model https://www.pharmiweb.com/press-release/2026-03-10/tiximed-announces-promising-preclinical-data-oral-tix100-prevents-weight-regain-after-glp-1-cessati Tue, 10 Mar 2026 08:22:00 +00:00 229941 Unreasonable Labs Raises $13.5M Funding Round to Scale Superintelligence for Knowledge Discovery https://www.pharmiweb.com/press-release/2026-03-10/unreasonable-labs-raises-135m-funding-round-to-scale-superintelligence-for-knowledge-discovery Tue, 10 Mar 2026 08:00:00 +00:00 229942 TerSera Therapeutics Announces Closing of Divestiture of Infusion Specialty Therapies Business Unit to ESTEVE https://www.pharmiweb.com/press-release/2026-03-10/tersera-therapeutics-announces-closing-of-divestiture-of-infusion-specialty-therapies-business-unit Tue, 10 Mar 2026 05:54:00 +00:00 229934 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-10/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Tue, 10 Mar 2026 05:32:00 +00:00 229935 Notice of Annual General Meeting in FluoGuide A/S https://www.pharmiweb.com/press-release/2026-03-10/notice-of-annual-general-meeting-in-fluoguide-as Tue, 10 Mar 2026 01:05:00 +00:00 229940 ConnectiveRx Advances Clinically Integrated Provider Engagement Network https://www.pharmiweb.com/press-release/2026-03-10/connectiverx-advances-clinically-integrated-provider-engagement-network Tue, 10 Mar 2026 04:33:00 +00:00 229919 kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics https://www.pharmiweb.com/press-release/2026-03-10/kyronbio-announces-strategic-partnership-with-servier-to-advance-precision-glycosylation-in-antibody-therapeutics Tue, 10 Mar 2026 04:19:10 +00:00 229937 BIOCAPTIVA secures £1.58M to transform how blood samples are prepared for liquid biopsy https://www.pharmiweb.com/press-release/2026-03-10/biocaptiva-secures-158m-to-transform-how-blood-samples-are-prepared-for-liquid-biopsy Tue, 10 Mar 2026 04:18:12 +00:00 229936 Immutep Partners with Flex Databases to Digitize Clinical Trial Documentation https://www.pharmiweb.com/press-release/2026-03-10/immutep-partners-with-flex-databases-to-digitize-clinical-trial-documentation Tue, 10 Mar 2026 10:56:35 +00:00 229901 OMRON Healthcare releases new Women's Heart Health Factbook https://www.pharmiweb.com/press-release/2026-03-10/omron-healthcare-releases-new-womens-heart-health-factbook Tue, 10 Mar 2026 01:25:49 +00:00 229857 SignaCor named winner of Discovery Spark programme, receiving £250K from Zinc VC https://www.pharmiweb.com/press-release/2026-03-09/signacor-named-winner-of-discovery-spark-programme-receiving-250k-from-zinc-vc Mon, 09 Mar 2026 02:29:33 +00:00 229833 CueZen AI Demonstrates Nation-Scale Health Impact in Singapore https://www.pharmiweb.com/press-release/2026-03-10/cuezen-ai-demonstrates-nation-scale-health-impact-in-singapore Tue, 10 Mar 2026 04:00:00 +00:00 229920 Odyssey Therapeutics Appoints H. Martin Seidel, Ph.D., to Scientific Advisory Board https://www.pharmiweb.com/press-release/2026-03-10/odyssey-therapeutics-appoints-h-martin-seidel-phd-to-scientific-advisory-board Tue, 10 Mar 2026 04:00:00 +00:00 229921 DTG Appoints Philip Sullivan Executive Vice President https://www.pharmiweb.com/press-release/2026-03-10/dtg-appoints-philip-sullivan-executive-vice-president Tue, 10 Mar 2026 04:00:00 +00:00 229922 Trialbee Appoints Accomplished Life Sciences Executive Rick Riegel to Board of Directors to Accelerate Global Patient Recruitment for Clinical Trials https://www.pharmiweb.com/press-release/2026-03-10/trialbee-appoints-accomplished-life-sciences-executive-rick-riegel-to-board-of-directors-to-accelera Tue, 10 Mar 2026 04:00:00 +00:00 229926 Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® https://www.pharmiweb.com/press-release/2026-03-10/niagen-bioscience-launches-niagen-skincare-innovation-lab-and-debuts-dermatologist-tested-niagen-na Tue, 10 Mar 2026 03:32:00 +00:00 229923 Path Fertility Releases its Company Facts Sheet https://www.pharmiweb.com/press-release/2026-03-10/path-fertility-releases-its-company-facts-sheet Tue, 10 Mar 2026 10:05:00 +00:00 229933 MindImmune Secures $5 Million Strategic Investment from the Alzheimer’s Drug Discovery Foundation to Pioneer Immune-Driven Therapies for Alzheimer’s Disease https://www.pharmiweb.com/press-release/2026-03-10/mindimmune-secures-5-million-strategic-investment-from-the-alzheimer-s-drug-discovery-foundation-to Tue, 10 Mar 2026 03:00:00 +00:00 229924 Casma Therapeutics Receives MJFF Support to Advance Research on TRPML1 in Parkinson’s Disease https://www.pharmiweb.com/press-release/2026-03-10/casma-therapeutics-receives-mjff-support-to-advance-research-on-trpml1-in-parkinson-s-disease Tue, 10 Mar 2026 03:00:00 +00:00 229925 bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic https://www.pharmiweb.com/press-release/2026-03-10/bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-non Tue, 10 Mar 2026 02:47:00 +00:00 229907  Qlaris Bio Appoints Fred Guerard, Pharm.D., as President and Chief Executive Officer https://www.pharmiweb.com/press-release/2026-03-10/qlaris-bio-appoints-fred-guerard-pharmd-as-president-and-chief-executive-officer Tue, 10 Mar 2026 02:45:00 +00:00 229911 BeOne’s Tislelizumab Now Available in Ireland, Offering a New First Line Immunotherapy Option for Advanced Oesophageal Cancer https://www.pharmiweb.com/press-release/2026-03-10/beone-s-tislelizumab-now-available-in-ireland-offering-a-new-first-line-immunotherapy-option-for-advanced-oesophageal-cancer Tue, 10 Mar 2026 02:37:07 +00:00 229932 Peptilogics Begins Pivotal Trial of First-Ever Drug Designed to Cure Medical Device-Related Infections https://www.pharmiweb.com/press-release/2026-03-10/peptilogics-begins-pivotal-trial-of-first-ever-drug-designed-to-cure-medical-device-related-infectio Tue, 10 Mar 2026 02:05:00 +00:00 229908 For Couples in "Fertility Limbo," a Real-World Study Published by JARG Finds "Normal" Semen Analysis May Not Tell the Whole Story https://www.pharmiweb.com/press-release/2026-03-10/for-couples-in-fertility-limbo-a-real-world-study-published-by-jarg-finds-normal-semen-analysis Tue, 10 Mar 2026 09:55:00 +00:00 229930 JinIX Foundation Marks a New Chapter with a Partner Event at Its Retreat Center https://www.pharmiweb.com/press-release/2026-03-10/jinix-foundation-marks-a-new-chapter-with-a-partner-event-at-its-retreat-center Tue, 10 Mar 2026 09:15:00 +00:00 229929 VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026 https://www.pharmiweb.com/press-release/2026-03-10/vsee-unveils-worlds-first-autonomous-telehealth-ai-robot-at-himss-2026 Tue, 10 Mar 2026 09:56:00 +00:00 229928 Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx https://www.pharmiweb.com/press-release/2026-03-10/foundation-medicine-announces-expanded-participation-in-national-cancer-institute-s-combomatch-platf Tue, 10 Mar 2026 02:00:00 +00:00 229909 Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report https://www.pharmiweb.com/press-release/2026-03-10/innoviva-specialty-therapeutics-earns-strong-performance-rating-in-access-to-medicine-foundation-s-2 Tue, 10 Mar 2026 01:30:00 +00:00 229910 Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack https://www.pharmiweb.com/press-release/2026-03-10/aspire-biopharmas-buzz-bomb-tm-disrupts-energy-category-with-new-convenience-store-pack Tue, 10 Mar 2026 08:30:00 +00:00 229918 Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market https://www.pharmiweb.com/press-release/2026-03-10/protagenic-therapeutics-upgrades-from-otc-pink-to-otcqb-venture-market Tue, 10 Mar 2026 08:00:00 +00:00 229917 MAX BioPharma and Technomark Life Sciences Announce Investment and Partnership Agreement in Developing Oxysterol-Based Drug Candidate for MASH https://www.pharmiweb.com/press-release/2026-03-10/max-biopharma-and-technomark-life-sciences-announce-investment-and-partnership-agreement-in-developi Tue, 10 Mar 2026 08:00:00 +00:00 229916 Arthritis Foundation Announces 2026 Cycling Experiences With Three Ways to Ride and Support the Arthritis Community https://www.pharmiweb.com/press-release/2026-03-10/arthritis-foundation-announces-2026-cycling-experiences-with-three-ways-to-ride-and-support-the-arth Tue, 10 Mar 2026 08:00:00 +00:00 229915 Mipletamig Delivers Compelling 86% Clinical Benefit Rate and No CRS as Evaluable AML Patient Data increases by Nearly 50% https://www.pharmiweb.com/press-release/2026-03-10/mipletamig-delivers-compelling-86-clinical-benefit-rate-and-no-crs-as-evaluable-aml-patient-data-in Tue, 10 Mar 2026 08:05:00 +00:00 229914 Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing https://www.pharmiweb.com/press-release/2026-03-10/dermata-announces-appointment-of-kyra-peckaitis-as-vice-president-marketing Tue, 10 Mar 2026 08:30:00 +00:00 229913 Alligator Bioscience Strengthens Intellectual Property Protection for Bispecific Antibody Platform https://www.pharmiweb.com/press-release/2026-03-10/alligator-bioscience-strengthens-intellectual-property-protection-for-bispecific-antibody-platform Tue, 10 Mar 2026 08:45:00 +00:00 229912 C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology https://www.pharmiweb.com/press-release/2026-03-10/c-further-unveils-first-therapeutic-programmes-dedicated-to-paediatric-oncology Tue, 10 Mar 2026 12:00:00 +00:00 229895 Microbix's Clot-Buster Drug Project Advances https://www.pharmiweb.com/press-release/2026-03-10/microbixs-clot-buster-drug-project-advances Tue, 10 Mar 2026 07:00:00 +00:00 229906 Medicus Pharma Ltd. To Participate In The Longwood Miami CEO Forum https://www.pharmiweb.com/press-release/2026-03-10/medicus-pharma-ltd-to-participate-in-the-longwood-miami-ceo-forum Tue, 10 Mar 2026 07:30:00 +00:00 229905 Abselion Establishes US Subsidiary in Cambridge, MA https://www.pharmiweb.com/press-release/2026-03-10/abselion-establishes-us-subsidiary-in-cambridge-ma Tue, 10 Mar 2026 11:15:08 +00:00 229904 Symeres achieves ISO 27001 certification, reinforcing commitment to information security https://www.pharmiweb.com/press-release/2026-03-10/symeres-achieves-iso-27001-certification-reinforcing-commitment-to-information-security Tue, 10 Mar 2026 09:54:36 +00:00 229891 Crystec announces new strategic partnership with Joel Hi-Tech https://www.pharmiweb.com/press-release/2026-03-10/crystec-announces-new-strategic-partnership-with-joel-hi-tech Tue, 10 Mar 2026 09:52:29 +00:00 229884 Digital Musculoskeletal (MSK) Care Market: Growth, Opportunities, Key Players & Forecast Outlook 2030 https://www.pharmiweb.com/press-release/2026-03-10/digital-musculoskeletal-msk-care-market-growth-opportunities-key-players-forecast-outlook-2030 Tue, 10 Mar 2026 06:22:44 +00:00 229873 kyron.bio Announces Strategic Partnership with Servier to Advance Precision Glycosylation in Antibody Therapeutics https://www.pharmiweb.com/press-release/2026-03-09/kyronbio-announces-strategic-partnership-with-servier-to-advance-precision-glycosylation-in-antibody-therapeutics Mon, 09 Mar 2026 08:33:59 +00:00 229798 Zomedica to Review 2025 Financial Results and Highlight Equine Market Opportunity During March 27th "Fourth Friday at Four" Investor Webinar https://www.pharmiweb.com/press-release/2026-03-10/zomedica-to-review-2025-financial-results-and-highlight-equine-market-opportunity-during-march-27th Tue, 10 Mar 2026 06:30:00 +00:00 229898 Ministerial Visit to Athlone Laboratories: A Vision for the Future of Critical Medicines in Ireland https://www.pharmiweb.com/press-release/2026-03-10/ministerial-visit-to-athlone-laboratories-a-vision-for-the-future-of-critical-medicines-in-ireland Tue, 10 Mar 2026 10:48:16 +00:00 229897 Neuland to open commercial peptide facility as part of planned phased expansion https://www.pharmiweb.com/press-release/2026-03-10/neuland-to-open-commercial-peptide-facility-as-part-of-planned-phased-expansion-1 Tue, 10 Mar 2026 10:05:14 +00:00 229896 GigaDevice Expands GD25UF Series Density Empowering AI Computing with 1.2V Ultra-Low Power Storage https://www.pharmiweb.com/press-release/2026-03-10/gigadevice-expands-gd25uf-series-density-empowering-ai-computing-with-12v-ultra-low-power-storage Tue, 10 Mar 2026 10:00:00 +00:00 229877 OSE Immunotherapeutics Confirms Marc Le Bozec as Chief Executive Officer to Lead Next Phase of Strategic Growth https://www.pharmiweb.com/press-release/2026-03-10/ose-immunotherapeutics-confirms-marc-le-bozec-as-chief-executive-officer-to-lead-next-phase-of-strategic-growth Tue, 10 Mar 2026 09:56:50 +00:00 229894 Ondine Provides Update on US Phase 3 Pivotal Study https://www.pharmiweb.com/press-release/2026-03-10/ondine-provides-update-on-us-phase-3-pivotal-study Tue, 10 Mar 2026 09:54:56 +00:00 229892 Industry Veterans Launch Maprium – an innovative technology to drive efficiencies and compliance in global Managed Access Programmes (MAPS). https://www.pharmiweb.com/press-release/2026-03-10/industry-veterans-launch-maprium-an-innovative-technology-to-drive-efficiencies-and-compliance-in-global-managed-access-programmes-maps Tue, 10 Mar 2026 09:38:01 +00:00 229883 Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors https://www.pharmiweb.com/press-release/2026-03-10/kainova-therapeutics-announces-positive-phase-i-results-for-dt-9081-an-oral-ep4-receptor-antagonist-in-advanced-solid-tumors Tue, 10 Mar 2026 09:35:19 +00:00 229881 EnteroBiotix Announces Completion of Enrolment in Phase 2a Trial Evaluating EBX-102-02 Prior to Allogeneic Stem Cell Transplantation https://www.pharmiweb.com/press-release/2026-03-10/enterobiotix-announces-completion-of-enrolment-in-phase-2a-trial-evaluating-ebx-102-02-prior-to-allogeneic-stem-cell-transplantation Tue, 10 Mar 2026 09:25:22 +00:00 229879 Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development https://www.pharmiweb.com/press-release/2026-03-10/spago-nanomedical-strengthens-cmc-and-supply-capabilities-to-support-next-phase-of-tumorad-developme Tue, 10 Mar 2026 03:15:00 +00:00 229876 Theralogix Introduces OvaNAD+(TM) Egg Quality Support: An Innovative NAD+ Supplement for Reproductive and Ovarian Health https://www.pharmiweb.com/press-release/2026-03-10/theralogix-introduces-ovanadplus-tm-egg-quality-support-an-innovative-nadplus-supplement-for-reproductiv Tue, 10 Mar 2026 12:00:00 +00:00 229860 EOSE Lawsuit Alert: Eos Energy Manufacturing Issues Trigger Securities Fraud Lawsuit after 39% Stock Drop – Contact BFA Law before May 5 Deadline https://www.pharmiweb.com/press-release/2026-03-10-3/eose-lawsuit-alert-eos-energy-manufacturing-issues-trigger-securities-fraud-lawsuit-after-39-stock Tue, 10 Mar 2026 02:06:00 +00:00 229854 RSVR TAKE PRIVATE ANNOUNCEMENT: Reservoir Media, Inc. Shareholders are Notified of BFA Law’s Investigation into Reservoir Media’s potential $10.50 per share Take Private Transaction https://www.pharmiweb.com/press-release/2026-03-10-1/rsvr-take-private-announcement-reservoir-media-inc-shareholders-are-notified-of-bfa-law-s-investi Tue, 10 Mar 2026 12:32:00 +00:00 229846 Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union https://www.pharmiweb.com/press-release/2026-03-10-2/operio-group-named-distributor-for-schaefer-technologies-in-the-united-kingdom-and-european-union Tue, 10 Mar 2026 12:00:00 +00:00 229852 Transcat Appoints Jaime Irick as President and Chief Executive Officer https://www.pharmiweb.com/press-release/2026-03-09/transcat-appoints-jaime-irick-as-president-and-chief-executive-officer Mon, 09 Mar 2026 11:05:00 +00:00 229847 Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy https://www.pharmiweb.com/press-release/2026-03-09/prothena-announces-achievement-of-50-million-clinical-milestone-payment-from-novo-nordisk-related-t Mon, 09 Mar 2026 11:05:00 +00:00 229848 $DRVN Lawsuit Alert: Driven Brands Financial Restatement Triggers Securities Fraud Lawsuit after 39% Stock Drop – Contact BFA Law before May 8 Deadline https://www.pharmiweb.com/press-release/2026-03-09/drvn-lawsuit-alert-driven-brands-financial-restatement-triggers-securities-fraud-lawsuit-after-39 Mon, 09 Mar 2026 11:04:00 +00:00 229849 Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy https://www.pharmiweb.com/press-release/2026-03-09/vertex-announces-positive-week-36-interim-analysis-results-for-primary-and-all-secondary-endpoints-i Mon, 09 Mar 2026 11:02:00 +00:00 229850 Medicare's CBD Gamble: Is Washington About to Bypass the FDA Drug Approval System for Marijuana Drugs? https://www.pharmiweb.com/press-release/2026-03-09/medicares-cbd-gamble-is-washington-about-to-bypass-the-fda-drug-approval-system-for-marijuana-drug Mon, 09 Mar 2026 04:15:00 +00:00 229844 MaaT Pharma to Present Four Abstracts at the 52nd European Bone Marrow Transplantation Annual Meeting and to Highlight Clinigen-Hosted Industry Symposium on acute GvHD Management https://www.pharmiweb.com/press-release/2026-03-09/maat-pharma-to-present-four-abstracts-at-the-52nd-european-bone-marrow-transplantation-annual-meetin Mon, 09 Mar 2026 08:00:00 +00:00 229838 Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS https://www.pharmiweb.com/press-release/2026-03-09/hims-hers-health-investigation-initiated-kahn-swick-foti-llc-investigates-the-officers-and-dir Mon, 09 Mar 2026 07:46:00 +00:00 229839 Update to Faron's Financial Calendar and Date of the Annual General Meeting in 2026 https://www.pharmiweb.com/press-release/2026-03-09/update-to-farons-financial-calendar-and-date-of-the-annual-general-meeting-in-2026 Mon, 09 Mar 2026 02:00:00 +00:00 229841 Black Book Releases HIMSS26 Floor Guide Grouping Top Client-Rated Exhibitors by Strategic Category https://www.pharmiweb.com/press-release/2026-03-09/black-book-releases-himss26-floor-guide-grouping-top-client-rated-exhibitors-by-strategic-category Mon, 09 Mar 2026 01:00:00 +00:00 229836 CORRECTING and REPLACING QuantHealth Achieves Impressive 8x Financial Growth Across Life Sciences Engagements https://www.pharmiweb.com/press-release/2026-03-09/correcting-and-replacing-quanthealth-achieves-impressive-8x-financial-growth-across-life-sciences-en Mon, 09 Mar 2026 05:29:00 +00:00 229834 Nomination Committee for Biovica International AB for the 2026 Annual General Meeting https://www.pharmiweb.com/press-release/2026-03-09/nomination-committee-for-biovica-international-ab-for-the-2026-annual-general-meeting Mon, 09 Mar 2026 12:12:00 +00:00 229835 QuantHealth Achieves Impressive 8x Financial Growth Across Life Sciences Engagements https://www.pharmiweb.com/press-release/2026-03-09/quanthealth-achieves-impressive-8x-financial-growth-across-life-sciences-engagements Mon, 09 Mar 2026 04:00:00 +00:00 229827 AnovoRx Appoints Steve Fitzpatrick as Chief Executive Officer https://www.pharmiweb.com/press-release/2026-03-09/anovorx-appoints-steve-fitzpatrick-as-chief-executive-officer Mon, 09 Mar 2026 04:00:00 +00:00 229828 Verily and Samsung Collaborate to Accelerate Clinical Research with the Galaxy Watch and Pre Platform https://www.pharmiweb.com/press-release/2026-03-09/verily-and-samsung-collaborate-to-accelerate-clinical-research-with-the-galaxy-watch-and-pre-platfor Mon, 09 Mar 2026 04:00:00 +00:00 229829 GE HealthCare announces U.S. FDA 510(k) clearance for View, a next‑generation diagnostic viewer enabling anywhere‑access to radiologists https://www.pharmiweb.com/press-release/2026-03-09/ge-healthcare-announces-us-fda-510-k-clearance-for-view-a-next-generation-diagnostic-viewer-enab Mon, 09 Mar 2026 04:00:00 +00:00 229832 Ampco-Pittsburgh Corporation Announces Significant Increase in Customer Orders https://www.pharmiweb.com/press-release/2026-03-09/ampco-pittsburgh-corporation-announces-significant-increase-in-customer-orders Mon, 09 Mar 2026 03:30:00 +00:00 229830 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-09/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Mon, 09 Mar 2026 02:57:00 +00:00 229831 Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates https://www.pharmiweb.com/press-release/2026-03-09/spruce-biosciences-reports-full-year-2025-financial-results-and-provides-corporate-updates Mon, 09 Mar 2026 02:05:00 +00:00 229814 Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer https://www.pharmiweb.com/press-release/2026-03-09/spruce-biosciences-appoints-dale-hooks-an-accomplished-rare-disease-commercial-leader-as-chief-com Mon, 09 Mar 2026 02:00:00 +00:00 229815 enGene Reports First Quarter 2026 Financial Results and Provides Business Update https://www.pharmiweb.com/press-release/2026-03-09/engene-reports-first-quarter-2026-financial-results-and-provides-business-update Mon, 09 Mar 2026 02:00:00 +00:00 229816 Ionis announces changes to Board of Directors https://www.pharmiweb.com/press-release/2026-03-09/ionis-announces-changes-to-board-of-directors Mon, 09 Mar 2026 02:00:00 +00:00 229818 Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma https://www.pharmiweb.com/press-release/2026-03-09/bristol-myers-squibb-announces-positive-phase-3-results-from-the-successor-2-study-of-oral-mezigdomi Mon, 09 Mar 2026 01:59:00 +00:00 229817 Jaguar Health Strengthens Company's Balance Sheet by Restructuring and Reducing Royalty and Debt Obligations and Extinguishing Warrants https://www.pharmiweb.com/press-release/2026-03-09/jaguar-health-strengthens-companys-balance-sheet-by-restructuring-and-reducing-royalty-and-debt-obl Mon, 09 Mar 2026 09:00:00 +00:00 229826 Beacon Oral Specialists Enters Jacksonville with North Florida Oral & Facial Surgery Partnership https://www.pharmiweb.com/press-release/2026-03-09/beacon-oral-specialists-enters-jacksonville-with-north-florida-oral-facial-surgery-partnership Mon, 09 Mar 2026 08:00:00 +00:00 229825 Avant Brands Continues to Strengthen Balance Sheet with $1.77 Million Debt Retirement at $0.935 Per Unit https://www.pharmiweb.com/press-release/2026-03-09/avant-brands-continues-to-strengthen-balance-sheet-with-177-million-debt-retirement-at-0935-per Mon, 09 Mar 2026 08:00:00 +00:00 229824 Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build https://www.pharmiweb.com/press-release/2026-03-09/vanderbilt-report-coeptis-z-squared-merger-enters-final-stretch-closing-imminent-as-institution Mon, 09 Mar 2026 08:07:00 +00:00 229823 ZetrOZ Systems is a Premier Sponsor of Arthritis Foundation's Pathways Conference, Highlighting Drug Free Treatment Options for Knee Osteoarthritis https://www.pharmiweb.com/press-release/2026-03-09/zetroz-systems-is-a-premier-sponsor-of-arthritis-foundations-pathways-conference-highlighting-drug Mon, 09 Mar 2026 09:00:00 +00:00 229822 Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-girdle Muscular Dystrophy https://www.pharmiweb.com/press-release/2026-03-09/atamyo-therapeutics-presents-promising-results-in-the-first-patients-treated-with-its-ata-200-gene-t Mon, 09 Mar 2026 12:30:00 +00:00 229807 Wellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM) https://www.pharmiweb.com/press-release/2026-03-09/wellgistics-targets-70b-market-breakthrough-addressing-ozempic-glp-1-muscle-loss-with-forzet-tm Mon, 09 Mar 2026 07:40:00 +00:00 229819 Naobios and SGS partner to manufacture Respiratory Syncytial Virus (RSV) challenge agent https://www.pharmiweb.com/press-release/2026-03-09/naobios-and-sgs-partner-to-manufacture-respiratory-syncytial-virus-rsv-challenge-agent Mon, 09 Mar 2026 08:30:00 +00:00 229806 Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer https://www.pharmiweb.com/press-release/2026-03-09/genentech-provides-update-on-phase-iii-persevera-study-in-er-positive-advanced-breast-cancer Mon, 09 Mar 2026 09:10:00 +00:00 229796 Monthly Letter February - ADDA, Growth Capital and Preparations for Scaling https://www.pharmiweb.com/press-release/2026-03-09/monthly-letter-february-adda-growth-capital-and-preparations-for-scaling Mon, 09 Mar 2026 04:20:00 +00:00 229802 Biosensors Market Research Report, Analysis, Size, Share, Trends and Forecast 2035 https://www.pharmiweb.com/press-release/2026-03-09/biosensors-market-research-report-analysis-size-share-trends-and-forecast-2035 Mon, 09 Mar 2026 07:50:25 +00:00 229795 Dental Imaging Market Analysis, Size, Share, Top Companies and Research Report by 2035 https://www.pharmiweb.com/press-release/2026-03-09/dental-imaging-market-analysis-size-share-top-companies-and-research-report-by-2035 Mon, 09 Mar 2026 07:16:41 +00:00 229792 Plasmapheresis Market 2026 | Size, Share, Trends, and Growth by Forecast, 2035 https://www.pharmiweb.com/press-release/2026-03-09/plasmapheresis-market-2026-size-share-trends-and-growth-by-forecast-2035 Mon, 09 Mar 2026 07:01:46 +00:00 229790 Veterinary Software Market Analysis, Size, Share, Top Companies and Research Report by 2035 https://www.pharmiweb.com/press-release/2026-03-09/veterinary-software-market-analysis-size-share-top-companies-and-research-report-by-2035 Mon, 09 Mar 2026 06:38:07 +00:00 229787 Microfluidics Market Research Report, Analysis, Size, Share, Trends and Forecast 2035 https://www.pharmiweb.com/press-release/2026-03-09/microfluidics-market-research-report-analysis-size-share-trends-and-forecast-2035 Mon, 09 Mar 2026 06:13:29 +00:00 229785 Medical Radiation Shielding Market Strengthens with Increasing Healthcare Safety Regulations https://www.pharmiweb.com/press-release/2026-03-09/medical-radiation-shielding-market-strengthens-with-increasing-healthcare-safety-regulations Mon, 09 Mar 2026 04:51:22 +00:00 229782 Xytel India’s Role in Sustainable Industrial Growth and Innovation https://www.pharmiweb.com/press-release/2026-03-07/xytel-india-s-role-in-sustainable-industrial-growth-and-innovation Sat, 07 Mar 2026 05:10:28 +00:00 229770 Surgical Sutures Market: Growth Drivers, Trends, Challenges, and Regional Insights https://www.pharmiweb.com/press-release/2026-03-06/surgical-sutures-market-growth-drivers-trends-challenges-and-regional-insights Fri, 06 Mar 2026 05:33:32 +00:00 229719 Circulating Tumor Cells Market Gains Momentum as Liquid Biopsy Transforms Cancer Diagnostics https://www.pharmiweb.com/press-release/2026-03-06/circulating-tumor-cells-market-gains-momentum-as-liquid-biopsy-transforms-cancer-diagnostics Fri, 06 Mar 2026 05:03:13 +00:00 229717 Vicore Pharma to Present at Upcoming Investor Conferences https://www.pharmiweb.com/press-release/2026-03-09/vicore-pharma-to-present-at-upcoming-investor-conferences Mon, 09 Mar 2026 03:15:00 +00:00 229793 Egetis Receives Notice of Allowance for MCT8 Deficiency Composition Patent in the U.S. https://www.pharmiweb.com/press-release/2026-03-09/egetis-receives-notice-of-allowance-for-mct8-deficiency-composition-patent-in-the-us Mon, 09 Mar 2026 02:20:00 +00:00 229788 Lobe Sciences Announces Appointment of Mr. Mirza Rahimani, CPA, CA as Chief Financial Officer https://www.pharmiweb.com/press-release/2026-03-09/lobe-sciences-announces-appointment-of-mr-mirza-rahimani-cpa-ca-as-chief-financial-officer Mon, 09 Mar 2026 12:00:00 +00:00 229780 "The Cannabis Industry's Medical Pivot: Why Most Companies Are Already Ten Years Behind." https://www.pharmiweb.com/press-release/2026-03-08/the-cannabis-industrys-medical-pivot-why-most-companies-are-already-ten-years-behind Sun, 08 Mar 2026 04:10:00 +00:00 229778 All Home Care Matters Takes Over Leadership Role of AlzAuthors https://www.pharmiweb.com/press-release/2026-03-07/all-home-care-matters-takes-over-leadership-role-of-alzauthors Sat, 07 Mar 2026 06:20:00 +00:00 229773 Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories https://www.pharmiweb.com/press-release/2026-03-07/dipylon-medical-expands-access-to-clinical-microbiology-equipment-for-modern-diagnostic-laboratories Sat, 07 Mar 2026 06:15:00 +00:00 229771 U.S. FDA Approves Bristol Myers Squibb’s Sotyktu® (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis https://www.pharmiweb.com/press-release/2026-03-07/us-fda-approves-bristol-myers-squibb-s-sotyktu-deucravacitinib-for-the-treatment-of-adults-with Sat, 07 Mar 2026 05:59:00 +00:00 229767 Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit https://www.pharmiweb.com/press-release/2026-03-07/investor-notice-robbins-llp-informs-investors-of-the-soleno-therapeutics-inc-class-action-lawsuit Sat, 07 Mar 2026 05:29:00 +00:00 229768 Investor Notice: Robbins LLP Informs Investors of the Nektar Therapeutics Class Action Lawsuit https://www.pharmiweb.com/press-release/2026-03-07-1/investor-notice-robbins-llp-informs-investors-of-the-nektar-therapeutics-class-action-lawsuit Sat, 07 Mar 2026 12:48:00 +00:00 229764 Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG https://www.pharmiweb.com/press-release/2026-03-06/lone-star-funds-announces-agreement-to-acquire-the-capsules-health-ingredients-division-of-lonza-g Fri, 06 Mar 2026 08:30:00 +00:00 229759 HIMSS26 Must-See: Follow the Trophies to 70 Black Book Top Client-Rated Vendors https://www.pharmiweb.com/press-release/2026-03-06/himss26-must-see-follow-the-trophies-to-70-black-book-top-client-rated-vendors Fri, 06 Mar 2026 02:10:00 +00:00 229762 Number of Shares and Voting Rights of ADOCIA as of February 28th, 2026 https://www.pharmiweb.com/press-release/2026-03-06/number-of-shares-and-voting-rights-of-adocia-as-of-february-28th-2026 Fri, 06 Mar 2026 08:00:00 +00:00 229757 Rosen Law Firm Urges Boston Scientific Corporation (NYSE: BSX) Stockholders to Contact the Firm for Information About Their Rights https://www.pharmiweb.com/press-release/2026-03-06/rosen-law-firm-urges-boston-scientific-corporation-nyse-bsx-stockholders-to-contact-the-firm-for Fri, 06 Mar 2026 07:42:00 +00:00 229758 From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry's Reckoning Is Coming https://www.pharmiweb.com/press-release/2026-03-06/from-billion-dollar-hemp-drinks-to-fda-cease-and-desist-letters-the-cannabis-industrys-reckoning-i Fri, 06 Mar 2026 01:47:00 +00:00 229761 Buckingham Center for Facial Plastic Surgery Announces 2026 Castle Connolly Honors https://www.pharmiweb.com/press-release/2026-03-06/buckingham-center-for-facial-plastic-surgery-announces-2026-castle-connolly-honors Fri, 06 Mar 2026 12:15:00 +00:00 229756 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) https://www.pharmiweb.com/press-release/2026-03-06/first-trust-global-funds-plc-uk-regulatory-announcement-net-asset-value-s Fri, 06 Mar 2026 05:38:00 +00:00 229754 GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen® https://www.pharmiweb.com/press-release/2026-03-06/goodrx-to-expand-employer-sponsored-access-to-zepbound-kwikpen Fri, 06 Mar 2026 05:00:00 +00:00 229755 New England Journal of Medicine Publishes Phase III ALLEGORY Data Showing Genentech’s Gazyva Significantly Reduces Disease Activity in the Most Common Form of Lupus https://www.pharmiweb.com/press-release/2026-03-06/new-england-journal-of-medicine-publishes-phase-iii-allegory-data-showing-genentech-s-gazyva-signifi Fri, 06 Mar 2026 04:45:00 +00:00 229752 ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 https://www.pharmiweb.com/press-release/2026-03-06/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2025-results-march-17-2026 Fri, 06 Mar 2026 08:00:00 +00:00 229751 Smoke Free Sweden: Nicotine Pouch Restrictions Deprive Canadian Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-nicotine-pouch-restrictions-deprive-canadian-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 01:33:00 +00:00 229745 Smoke Free Sweden: Romanian Restrictions Deprive Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-romanian-restrictions-deprive-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 01:10:00 +00:00 229748 Smoke Free Sweden: Spain’s Nicotine Pouch Ban Will Deprive Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-spain-s-nicotine-pouch-ban-will-deprive-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 01:07:00 +00:00 229746 Smoke Free Sweden: Nicotine Pouch Restrictions Deprive German Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-nicotine-pouch-restrictions-deprive-german-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 01:02:00 +00:00 229747 Smoke Free Sweden: Pakistan’s Stance on Nicotine Pouches Deprives Women of a Safer Way to Quit Tobacco https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-pakistan-s-stance-on-nicotine-pouches-deprives-women-of-a-safer-way-to-quit-tobac Fri, 06 Mar 2026 12:59:00 +00:00 229738 Smoke Free Sweden: Restrictions on Nicotine Pouches Would Deprive Korean Women of Their Best Tool for Quitting Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-restrictions-on-nicotine-pouches-would-deprive-korean-women-of-their-best-tool-fo Fri, 06 Mar 2026 12:54:00 +00:00 229743 Smoke Free Sweden: Australian Restrictions Deprive Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-australian-restrictions-deprive-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 12:40:00 +00:00 229739 Smoke Free Sweden: Legal Limbo on Nicotine Pouches Deprives Brazil’s Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-legal-limbo-on-nicotine-pouches-deprives-brazil-s-women-of-best-tool-to-quit-smok Fri, 06 Mar 2026 12:38:00 +00:00 229740 Smoke Free Sweden: Restrictions on Nicotine Pouches Would Deprive Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-restrictions-on-nicotine-pouches-would-deprive-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 12:35:00 +00:00 229741 Smoke Free Sweden: Brussels Warned Against Depriving Women of Best Tool to Quit Smoking https://www.pharmiweb.com/press-release/2026-03-06/smoke-free-sweden-brussels-warned-against-depriving-women-of-best-tool-to-quit-smoking Fri, 06 Mar 2026 12:28:00 +00:00 229742 Thermo Fisher Scientific opens new distribution centre in Ireland https://www.pharmiweb.com/press-release/2026-03-06/thermo-fisher-scientific-opens-new-distribution-centre-in-ireland Fri, 06 Mar 2026 10:14:03 +00:00 229744 Global Testosterone Booster Market Outlook: Navigating Trends, Growth Drivers, and Strategic Opportunities (2026-2035) https://www.pharmiweb.com/press-release/2026-03-06/global-testosterone-booster-market-outlook-navigating-trends-growth-drivers-and-strategic-opportunities-2026-2035 Fri, 06 Mar 2026 06:27:33 +00:00 229728 Smart Pill Technology Market Analysis, Size, Share, Top Companies and Research Report by 2035 https://www.pharmiweb.com/press-release/2026-03-06/smart-pill-technology-market-analysis-size-share-top-companies-and-research-report-by-2035 Fri, 06 Mar 2026 06:23:52 +00:00 229726 Global Dental CAD/CAM Dental Prosthesis Market: Precision Redefining the Future of Restorative Dentistry https://www.pharmiweb.com/press-release/2026-03-06/global-dental-cadcam-dental-prosthesis-market-precision-redefining-the-future-of-restorative-dentistry Fri, 06 Mar 2026 06:17:35 +00:00 229724 Orthodontics Market 2026 | Size, Share, Trends, and Growth by Forecast, 2035 https://www.pharmiweb.com/press-release/2026-03-06/orthodontics-market-2026-size-share-trends-and-growth-by-forecast-2035 Fri, 06 Mar 2026 06:45:01 +00:00 229734 Global Hemophilia Therapeutics Market: Navigating the Era of Genetic Innovation and Prophylactic Excellence https://www.pharmiweb.com/press-release/2026-03-06/global-hemophilia-therapeutics-market-navigating-the-era-of-genetic-innovation-and-prophylactic-excellence Fri, 06 Mar 2026 06:43:53 +00:00 229732 Viral Sensitizers Market: The Silent Engine Powering the Future of Biotherapy [2026-2035 Report] https://www.pharmiweb.com/press-release/2026-03-06/viral-sensitizers-market-the-silent-engine-powering-the-future-of-biotherapy-2026-2035-report Fri, 06 Mar 2026 06:34:34 +00:00 229730 Medincell Announces Successful c. €48 Million Private Placement https://www.pharmiweb.com/press-release/2026-03-06/medincell-announces-successful-c-48-million-private-placement Fri, 06 Mar 2026 10:00:00 +00:00 229736 Investor Notice: Robbins LLP Informs Investors of the Aquestive Therapeutics, Inc. Class Action Lawsuit https://www.pharmiweb.com/press-release/2026-03-06/investor-notice-robbins-llp-informs-investors-of-the-aquestive-therapeutics-inc-class-action-laws Fri, 06 Mar 2026 03:14:00 +00:00 229710 Investor Notice: Robbins LLP Informs Investors of the Boston Scientific Corporation Class Action Lawsuit https://www.pharmiweb.com/press-release/2026-03-06-8/investor-notice-robbins-llp-informs-investors-of-the-boston-scientific-corporation-class-action-law Fri, 06 Mar 2026 02:56:00 +00:00 229704 Oasis Urges Shareholders to Oppose Kobayashi Pharma’s Transition to a Company with an Audit and Supervisory Committee at AGM (Securities Code: 4967 JT) https://www.pharmiweb.com/press-release/2026-03-06/oasis-urges-shareholders-to-oppose-kobayashi-pharma-s-transition-to-a-company-with-an-audit-and-supe Fri, 06 Mar 2026 02:00:00 +00:00 229709 Riassunto: GAIA e Daiichi Sankyo Europe firmano un accordo di partnership esclusiva per lanciare la terapia digitale di nuova generazione per la cura cardiovascolare in Europa. https://www.pharmiweb.com/press-release/2026-03-06-9/riassunto-gaia-e-daiichi-sankyo-europe-firmano-un-accordo-di-partnership-esclusiva-per-lanciare-la Fri, 06 Mar 2026 01:32:00 +00:00 229706 GAIA et Daiichi Sankyo Europe concluent un partenariat exclusif pour lancer une thérapie numérique de nouvelle génération pour les soins cardiovasculaires en Europe. https://www.pharmiweb.com/press-release/2026-03-06/gaia-et-daiichi-sankyo-europe-concluent-un-partenariat-exclusif-pour-lancer-une-thérapie-numérique-d Fri, 06 Mar 2026 01:32:00 +00:00 229707 Riassunto: GAIA e Daiichi Sankyo Europe firmano un accordo di partnership esclusiva per lanciare la terapia digitale di nuova generazione per la cura cardiovascolare in Europa. https://www.pharmiweb.com/press-release/2026-03-06/riassunto-gaia-e-daiichi-sankyo-europe-firmano-un-accordo-di-partnership-esclusiva-per-lanciare-la Fri, 06 Mar 2026 01:32:00 +00:00 229708 Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones https://www.pharmiweb.com/press-release/2026-03-06-1/contineum-therapeutics-reports-fourth-quarter-2025-financial-results-affirms-key-clinical-developme Fri, 06 Mar 2026 12:05:00 +00:00 229689 TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance https://www.pharmiweb.com/press-release/2026-03-06-2/trisalus-life-sciences-reports-fourth-quarter-and-year-end-2025-results-and-reaffirms-2026-revenue-g Fri, 06 Mar 2026 12:01:00 +00:00 229691 Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update https://www.pharmiweb.com/press-release/2026-03-06-3/lineage-cell-therapeutics-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-b Fri, 06 Mar 2026 12:01:00 +00:00 229693 Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights https://www.pharmiweb.com/press-release/2026-03-06-7/evommune-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-highlight Fri, 06 Mar 2026 12:01:00 +00:00 229702 Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.pharmiweb.com/press-release/2026-03-06-4/immunome-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Fri, 06 Mar 2026 12:00:00 +00:00 229695 Kallyope to Present Phase 2b Study Results for Elismetrep for the Acute Treatment of Migraine at the 2026 American Academy of Neurology Annual Meeting https://www.pharmiweb.com/press-release/2026-03-06-5/kallyope-to-present-phase-2b-study-results-for-elismetrep-for-the-acute-treatment-of-migraine-at-the Fri, 06 Mar 2026 12:00:00 +00:00 229697 Vertex to Participate in Upcoming March Investor Conferences https://www.pharmiweb.com/press-release/2026-03-06-6/vertex-to-participate-in-upcoming-march-investor-conferences Fri, 06 Mar 2026 12:00:00 +00:00 229699